Ryanair Discontinues Afrikaans Test Following Outcry In South Africa
Ryanair Holdings plc (NASDAQ:RYAAY) has eliminated a requirement for South African travelers to confirm their nationality before flying by…
Trending On Twitter: Was Chris Evans Photoshopped In Disney Publicity Pics?
Chris Evans found himself trending on Twitter (NYSE: TWTR) this weekend when speculation arose on whether the actor was photoshopped into pictures taken at the Walt Disney Co.’s (NYSE: DIS) Pixar Pier
Ryanair Expects Strong Summer Bookings: Reuters
Ryanair Holdings (NASDAQ:RYAAY) Chief Executive Michael O’Leary stated on Wednesday that bookings for the summer looked very strong, adding…
BofA Cuts Boeing Target On Higher Risk Profile
Boeing Co (NYSE: BA) could face several “unexpected” challenges in the near term, according to BofA Securities.
The Boeing Analyst: Ronald Epstein reiterated a Neutral rating on Boeing, while trimming the price target from $180 to $150.
Ryanair CEO Thinks Boeing Management Needs A Reboot: CNBC
Ryanair Holdings plc (NASDAQ:RYAAY) CEO Michael O’Leary following the FY22 results, told CNBC that the company had been “very disappointed with…
Ryanair FY22 Loss Narrows, Expects To Return To Profitability In FY23
Ryanair Holdings plc (NASDAQ:RYAAY) reported FY22 revenue growth of 193% year-over-year to €4.8 billion. The company reported an FY22 net…
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Earnings Preview: Ryanair Holdings
Ryanair Holdings (NASDAQ:RYAAY) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement.
Analysts estimate that Ryanair Holdings will report an earnings per share (EPS) of $-1.02.
Raymond James Maintains Outperform on Ryanair Holdings, Lowers Price Target to $125
Raymond James analyst Savanthi Syth maintains Ryanair Holdings (NASDAQ:RYAAY) with a Outperform and lowers the price target from $138 to $125.